Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Teva’s Zoloft Generic Remains On The Shelf

This article was originally published in The Pink Sheet Daily

Executive Summary

Teva has not yet launched its generic version of Pfizer's antidepressant Zoloft (sertraline), although it received FDA approval June 30

You may also be interested in...

FDA Approves Teva’s Generic Zoloft

Teva received FDA final approval for its generic version of Pfizer's antidepressant Zoloft (sertraline) June 30

Pfizer Prepares For Zoloft Authorized Generic Entry Following Teva’s Launch

Pfizer's blockbuster antidepressant sertraline loses exclusivity June 30.

Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind

Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts